Victory Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $143K | Buy |
12,337
+101
| +0.8% | +$1.17K | ﹤0.01% | 2295 |
|
2025
Q1 | $107K | Sell |
12,236
-102
| -0.8% | -$890 | ﹤0.01% | 2303 |
|
2024
Q4 | $177K | Sell |
12,338
-299
| -2% | -$4.29K | ﹤0.01% | 2261 |
|
2024
Q3 | $285K | Sell |
12,637
-91
| -0.7% | -$2.06K | ﹤0.01% | 2149 |
|
2024
Q2 | $248K | Sell |
12,728
-203
| -2% | -$3.95K | ﹤0.01% | 2150 |
|
2024
Q1 | $485K | Buy |
12,931
+193
| +2% | +$7.24K | ﹤0.01% | 1991 |
|
2023
Q4 | $713K | Buy |
12,738
+2,515
| +25% | +$141K | ﹤0.01% | 1862 |
|
2023
Q3 | $422K | Sell |
10,223
-16,261
| -61% | -$671K | ﹤0.01% | 2038 |
|
2023
Q2 | $1.48M | Sell |
26,484
-1,241
| -4% | -$69.3K | ﹤0.01% | 1500 |
|
2023
Q1 | $1.55M | Buy |
27,725
+18,017
| +186% | +$1.01M | ﹤0.01% | 1482 |
|
2022
Q4 | $354K | Sell |
9,708
-5
| -0.1% | -$182 | ﹤0.01% | 2122 |
|
2022
Q3 | $277K | Buy |
+9,713
| New | +$277K | ﹤0.01% | 2277 |
|
2022
Q1 | – | Sell |
-23,560
| Closed | -$3.51M | – | 2811 |
|
2021
Q4 | $3.51M | Sell |
23,560
-21,455
| -48% | -$3.2M | ﹤0.01% | 1405 |
|
2021
Q3 | $6.55M | Sell |
45,015
-8,584
| -16% | -$1.25M | 0.01% | 1247 |
|
2021
Q2 | $10.5M | Sell |
53,599
-124,652
| -70% | -$24.4M | 0.01% | 1108 |
|
2021
Q1 | $32.3M | Sell |
178,251
-2,381
| -1% | -$431K | 0.03% | 734 |
|
2020
Q4 | $25.6M | Sell |
180,632
-23,584
| -12% | -$3.34M | 0.03% | 776 |
|
2020
Q3 | $25.5M | Sell |
204,216
-27,053
| -12% | -$3.37M | 0.03% | 691 |
|
2020
Q2 | $20.7M | Sell |
231,269
-485,209
| -68% | -$43.3M | 0.03% | 765 |
|
2020
Q1 | $44.7M | Buy |
716,478
+261,584
| +58% | +$16.3M | 0.04% | 614 |
|
2019
Q4 | $34.7M | Sell |
454,894
-106,780
| -19% | -$8.14M | 0.04% | 622 |
|
2019
Q3 | $28.3M | Buy |
+561,674
| New | +$28.3M | 0.04% | 665 |
|